This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday

Apogee Therapeutics, Inc. +1.82%
Arcturus Therapeutics +0.11%
Carnival Corporation +6.99%
Tandem Diabetes Care, Inc. +2.59%
Union Pacific Corporation +0.03%

Apogee Therapeutics, Inc.

APGE

92.20

+1.82%

Arcturus Therapeutics

ARCT

8.85

+0.11%

Carnival Corporation

CCL

29.22

+6.99%

Tandem Diabetes Care, Inc.

TNDM

20.61

+2.59%

Union Pacific Corporation

UNP

251.14

+0.03%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Jamie Rollo upgraded Carnival Corp (NYSE:CCL) from Equal-Weight to Overweight and cut the price target from $33 to $31. Carnival shares closed at $24.16 on Wednesday. See how other analysts view this stock.
  • Truist Securities analyst Richard Newitter upgraded Tandem Diabetes Care Inc (NASDAQ:TNDM) from Hold to Buy and raised the price target from $27 to $35. Tandem Diabetes Care shares closed at $23.85 on Wednesday. See how other analysts view this stock.
  • Evercore ISI Group analyst Jonathan Chappell upgraded Union Pacific Corp (NYSE:UNP) from In-Line to Outperform and raised the price target from $260 to $262. Union Pacific shares closed at $236.57 on Wednesday. See how other analysts view this stock.

Considering buying UNP stock? Here’s what analysts think:

Photo via Shutterstock